Morphic Therapeutic announced the appointment of Susannah Gray to its Board of Directors. Ms. Gray was most recently the executive vice president of finance and strategy at Royalty Pharma. Susannah Gray was executive vice president and chief financial officer at Royalty Pharma from 2005-2019. Simultaneously, Otello Stampacchia, Ph.D., has stepped down from the Morphic Board of Directors. Further, Vikas Goyal has determined that he will not stand for re-election to the Morphic Board of Directors when his current term expires.